Kuchyne na miru

Latest

Creating an ‘Unbossed’ Environment in the Workplace

Daniel Manea, Novartis’s US head of people and organization, talks about how the company’s cultural transformation aims to strengthen and empower its talent base.

Compliance Disruptors: Bryant Aaron and Jennifer McGee

Big pharma compliance leaders Bryant Aaron (Novartis) and Jennifer McGee (Otsuka) discuss the strategic move to principles-based policies at their companies and the impact of other emerging forces influencing industry compliance practice.

Asia’s Complex Compliance Landscape

A look at some of the key pharma compliance challenges prevalent in the Asia-Pacific region.

Compliance as Usual Doesn’t Cut it Anymore

How pharma companies can bolster their quality management programs to meet FDA’s evolving compliance requirements.

Pharm Exec Video

A Conversation with Greg Apostol, National Vice President, Key Account Management, Alkermes

Greg Apostol, National Vice President, Key Account Management, Alkermes, talks with Pharm Exec's Editorial Director Lisa Henderson, at the 2019 18th Annual eyeforpharma Philadelphia Conference, Expo & Awards.

A Conversation with Amy Nicole Nayar, Head of Global Patient Relations, AbbVie

Editorial Director, Lisa Henderson catches up with Amy Nicole Nayar, Head of Global Patient Relations, AbbVie, at the 2019 18th Annual eyeforpharma Philadelphia Conference, Expo & Awards.

A Conversation with Chris Sellin, Head of Operational Excellence & Analytics, Takeda (Formerly Shire)

Pharm Exec's Editorial Director, Lisa Henderson catches up with Chris Sellin, Head of Operational Excellence & Analytics, Takeda (Formerly Shire), at the 2019 18th Annual eyeforpharma Philadelphia Conference, Expo & Awards.

New & Noteworthy

FDA Maps Pathway to More Accessible Biosimilars

New guidances open the door to interchangeables and less costly insulin.

Shared Understanding Creates Culture

While culture may "eat" strategy, shared understanding creates both culture and strategy, write Steve Figman and Sean Robertson.

3 Tips to Manage Multiple Agency Partners

Justin Grossman outlines three practices that are key to navigating today’s multiplayer agency landscape — and getting more value from each external vendor.

Pharm Exec’s 15th Annual Press Audit: The Opioid Crisis Dominates the News

The opioid crisis dominated the news in this year’s annual audit of press coverage of the pharmaceutical industry. Stephen J. Porth and George P. Sillup report.

From the Editor

Top Trends, Takeaways from DIA

Highlighting the biggest observations from this year's DIA Annual Meeting—topics likely to continue to dominate industry headlines for the foreseeable future.

Pharm Exec 50 Hints to Rest of ’19

Our latest report of the top 50 biopharma companies provides a nice springboard to the coverage we have in store for you in the year's second half.

eBooks

Emerging BioPharma: Your Guide to Clinical and Commercial Considerations

This eBook will focus on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways. 

View all eBooks

PEspeaks

Pharm Exec's Top 50 Companies 2019

Our 19th annual listing reveals some interesting maneuvering of ranks, as companies focus on diversification, big-brand expansions, and positioning a new wave of products to compete in an advancing but complex future treatment market.

Incentivizing Lower List Prices

In the third in a series of articles summarizing efforts to put each of the “American Patients First” blueprint's four strategies into action, Rick Kelly and Nisha Desai focus on “Incentivizing Lower List Prices.”

European Pricing Talks: A lot of Smoke—or is it Fire?

What are we to make of the simmering public and political angst, asks Reflector

Pharma & Biotech: Financial Pulse-Check, Outlook

A review of market performance and trends in 2018 and first quarter of 2019 for the life sciences industry.

Interviews

Creating an ‘Unbossed’ Environment in the Workplace

Daniel Manea, Novartis’s US head of people and organization, talks about how the company’s cultural transformation aims to strengthen and empower its talent base.

Cell and Gene Therapy: Delivering the Product

Cell One Partners' George Goldberger discusses the issues that new and emerging cell and gene therapy companies face on the road to commercialization.

LEO Pharma: Driving Compliance in Asia

See Li Lynn, LEO Pharma’s HR Manager, South Asia, talks about how LEO is managing the compliance challenges in Asia.

Resolving a Key Bottleneck in NASH R&D

Jan Lichtenberg, Ph.D, and Scott Friedman, MD, talk about the growing interest in nonalcoholic steatohepatitis (NASH) in the pharma industry, the complexities of modeling the disease, and what this means for drug development efforts.

Seizing the Opportunity in Europe

Bruno Wohlschlegel, European head of Merck KGaA, Darmstadt, Germany's Healthcare business, outlines the highlights of his career and talks about how his vision for Europe draws strength from the region’s diversity to advance collaboration and progress.

Insights: How Biopharma is Applying AI and Machine Learning

Gabe Musso, Chief Scientific Officer of BioSymetrics, talks about insights around how AI and ML are being used in biopharma.

Regulatory

Incentivizing Lower List Prices

In the third in a series of articles summarizing efforts to put each of the “American Patients First” blueprint's four strategies into action, Rick Kelly and Nisha Desai focus on “Incentivizing Lower List Prices.”

FDA Maps Pathway to More Accessible Biosimilars

New guidances open the door to interchangeables and less costly insulin.

European Pricing Talks: A lot of Smoke—or is it Fire?

What are we to make of the simmering public and political angst, asks Reflector

PIE is Good for You: Drive Patient Access by Embracing FDA's Final Guidance

R&D organizations can leverage FDA’s final guidance on pre-approval information exchange, otherwise known as PIE, to engage with payers prior to regulatory approval and commercial launch.

piratecodex.us

http://profvest.com

читайте здесь www.profvest.com
lorem ipsum